Gout Tophus

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Gout Tophus trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06669000

Time Required to Dissolve Urate Deposits

Gout is characterized by episodes of acute arthritis of the lower limbs due to intermittent activation of innate immunity in the joints where urate crystals hav…

France250 participantsStarted 2024-09-24Updated 2026-02-19

Treatment: Standard X-Rays, Ultrasound

All recent trials (19 shown)

Not Yet RecruitingNot Applicable

NCT07657156

Musculoskeletal Ultrasound for Differentiating Rheumatoid and Gouty Arthritis

Rheumatoid arthritis (RA) and gouty arthritis (GA) are two common forms of joint inflammation that can present with very similar physical symptoms, making them…

Location not specified100 participantsStarted 2026-07Updated 2026-06-18

CompletedNot Applicable

NCT03162341

Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit

The objective of this research is to evaluate the correlation between DECT and US explorations performed in a routine clinical setting for the measurement of ch…

France60 participantsStarted 2017-08-10Updated 2026-04-28

Treatment:

Gout Tophus

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Time Required to Dissolve Urate Deposits

All recent trials (19 shown)

Musculoskeletal Ultrasound for Differentiating Rheumatoid and Gouty Arthritis

Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Time Required to Dissolve Urate Deposits

All recent trials (19 shown)

Musculoskeletal Ultrasound for Differentiating Rheumatoid and Gouty Arthritis

Study of the Correlation Between UltraSonography and Dual-Energy Computed Tomography Assessment of Urate Deposit

Treat-to-target by Email During Urate-lowering Therapy in Gout

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

Evolution of Tophus and Erosions of Hands and Feet at DECT

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers

Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

A Exploratory Trial of WTX221 in Refractory Gout Patients

Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat

Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout

Febuxostat Versus Allopurinol Control Trial in Subjects With Gout

Efficacy and Safety of Oral Febuxostat in Participants With Gout

Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.

Dose-Response, Safety and Efficacy of Febuxostat in Subjects With Gout

Long-Term Safety of Febuxostat in Subjects With Gout.

Magnetic Resonance Imaging in Subjects With Gouty Tophi

Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010

Validation Study of Physical Measurement of Tophi